Pharmacovigilance and Safety Assessment


The session on Pharmacovigilance and Safety Assessment focuses on monitoring the safety and efficacy of medicinal plant-based products. Experts will discuss methodologies for adverse event reporting, risk assessment, and post-market surveillance. Discussions will encompass regulatory requirements, including reporting timelines and signal detection. Attendees can expect insights into the evaluation of potential herb-drug interactions and toxicity profiles. This session provides a critical platform for researchers, pharmacists, and regulatory professionals to exchange knowledge on ensuring the safe use of medicinal plant-based products, safeguarding public health while advancing the field of natural products in healthcare.


    Related Conference of Pharmacovigilance and Safety Assessment

    April 30-30, 2024

    14th International Conference on Womens Health and Cancer Cure

    Amsterdam, Netherlands
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands
    August 20-21, 2024

    11th World Summit on Epilepsy and Bipolar Disorders

    Montreal, Canada
    September 26-27, 2024

    7th Annual Congress on Emergency Medicine and Acute Care

    Amsterdam, Netherlands
    October 14-15, 2024

    11th World Machine Learning and Deep learning Conference

    Barcelona, Spain

    Pharmacovigilance and Safety Assessment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in